Physician profile
William M Scaljon
NPI 1164472643
$2,608.60
in general payments reported to CMS, 2019-2025
23 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $294 · 2021: $602 · 2022: $761 · 2023: $370 · 2024: $183 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $611.88 | 2021-2022 | |
| Astellas Pharma US INC | $373.60 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $367.95 | 2023-2025 | Orgovyx, Gemtesa |
| Rochester Medical Corporation | $266.33 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $163.84 | 2023 | Bard Urinary Drainage Bag |
| Abbvie INC. | $151.31 | 2020-2024 | |
| Endo Pharmaceuticals INC. | $129.95 | 2019-2023 | Xiaflex, Aveed |
| Angiodynamics, INC. | $67.71 | 2022 | |
| Dentsply Ih INC. | $64.49 | 2019-2021 | |
| Urovant Sciences INC | $61.29 | 2021-2022 | |
| Smith+Nephew, INC. | $46.78 | 2025 | Grafix, Stravix |
| Coloplast Corp | $39.01 | 2020-2022 | |
| Medtronic, INC. | $35.90 | 2023 | Interstim |
| Boston Scientific Corporation | $34.76 | 2019 | |
| Blue Earth Diagnostics | $32.67 | 2019-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $26.35 | 2024 | Adstiladrin |
| Travere Therapeutics, INC. | $24.59 | 2019-2022 | |
| Pfizer INC. | $21.81 | 2021 | |
| Neotract INC. | $21.58 | 2020 | |
| Allergan, INC. | $20.70 | 2019 | |
| Olympus America INC. | $16.41 | 2022 | |
| Srs Medical Systems, INC. | $14.88 | 2022 | |
| Procept Biorobotics Corporation | $14.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Scaljon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.